Why BGPT?
logo

Traceable Claims in Biochemistry

Check mechanism and assay claims against the experiments and exact results that support them.Know what the science actually supports before you trust the answer.

Press Enter ↵ to search claims



    Explore by Goal












     Quick Explanation


    Battle-test of evidence: Cue2 (SMR-domain endonuclease) drives NGD triggered by ribosome collisions
    The provided best-evidence claim is supported by a 2026 study showing that, in yeast, the Hel2/ZNF598–Cue2 branch produces collision-dependent endonucleolytic cleavage that dominates upstream NGD when the alternative Syh1–Smy2/GIGYF2 branch is absent; it further links NGD endonucleolysis to a ribosome collision context and identifies SMG6 as the relevant endonuclease in the tested mammalian context (with N4BP2 not required for Cue2-like NGD there). However, this support is context- and model-system-dependent because the key demonstrations rely heavily on engineered reporter constructs and KO backgrounds, so generality to all endogenous transcripts/cell types remains a key uncertainty.
    Evidence source:



     Long Explanation


    Cue2 (SMR-domain endonuclease) + stalled ribosomes → NGD
    Below is a skeptical, evidence-weighted appraisal of the provided claim using only the included research record.
    Primary supporting paper:
    1) What the evidence directly shows (known vs inferred)
    • Known (from this study): In yeast NGD reporter assays, Cue2’s SMR-domain nuclease activity is reported as essential for an endonucleolytic cleavage step, and this cleavage predominates upstream under conditions where the Syh1–SMY2 arm is absent (contextual dominance rather than universal dominance across all scenarios).
    • Known (from this study): In the tested mammalian setup, SMG6 is identified as the endonuclease responsible for a 3′ NGD intermediate linked to frameshifting on poly-lysine sequences; and N4BP2 is reported as not required to fulfill Cue2’s role in that context.
    • Inferred (needs more direct validation across systems): That Cue2’s SMR-domain activity is the universal NGD endonuclease logic across all yeast transcripts and conditions. The authors’ own limitations emphasize reporter dependence and context dependence.
    2) Mechanistic map (what interacts with what)
    Interpretation discipline: This diagram summarizes the reported relationships at a high level. It does not quantify rates/efficiencies because no raw NGD cleavage fractions are provided in the supplied dataset.
    3) Evidence strength rubric (per claim fragment)
    How to read: The scores are a heuristic translating the supplied paper’s reported strengths and limitations into relative “confidence to support the fragment as universally true.” They are not statistical measures from the paper.
    4) Counterpoints & blind spots to actively test
    Reporter/KO dependence (largest limitation)
    • The study explicitly relies on engineered reporter constructs (including NGD-reporter variants) and KO lines; that can bias the observed endonucleolytic feature toward specific sequence contexts and collision/frameshift architectures rather than the full repertoire of endogenous NGD triggers.
    Species/branch divergence
    • The same paper supports a yeast Cue2 nuclease role but reports a mammalian SMG6 endonuclease role in the tested context. That makes it plausible that “Cue2 is the NGD endonuclease” is species- and scenario-dependent, not a universal principle.
    What would most falsify the “Cue2 explains NGD endonucleolysis” claim?
    • Find a mammalian context (or additional mammalian lineages) where Cue2-like SMR nuclease function causally mediates NGD endonucleolysis, or where SMG6 is not required for NGD cleavage outcomes—contrary to the tested context in the provided study.
    Measurement/readout ambiguity
    • The core mechanistic inference depends on mapping cleavage intermediates (e.g., upstream vs 3′ features) and on interpreting these as endonucleolytic NGD signatures. Without direct endogenous trancript-wide confirmation in the supplied record, some uncertainty remains about how directly reporter cleavage features map onto all endogenous NGD events.
    Most defensible bottom line (with confidence)
    Defensible:
    In yeast reporter contexts of collision-dependent mRNA decay, Cue2’s SMR-domain nuclease activity is supported as a required mechanistic contributor to the observed endonucleolytic NGD cleavage feature, with upstream cleavage predominance under specific pathway-compensation conditions.
    Not yet defensible as universal:
    As stated, the evidence does not fully establish that Cue2 is the endonuclease for NGD across all endogenous contexts and across mammals; the same study reports divergent endonuclease usage (SMG6 in its mammalian tested system) and emphasizes reporter/model-system limitations.
    Confidence level (from provided record only): ~0.75 for the yeast-reporter Cue2→NGD endonucleolysis claim; ~0.3 for universal/general claim across systems.
    Optional: run a BGPT “AI Scientist” pass
    This can attempt automated extraction/structuring of NGD-relevant mechanistic claims from the supplied full-text-derived record and propose additional evidence-check queries.


    Feedback:    

    Updated: April 30, 2026

     Hypothesis Graveyard


    A strongman claim that Cue2 universally mediates NGD endonucleolysis in all eukaryotes regardless of context; the supplied record instead supports yeast Cue2 and mammalian SMG6 in its tested systems, arguing against universality as-is.

     Science Art


    Best Evidence: Cue2 SMR domain endonuclease stalled ribosomes NGD Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending